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Abstract – Accumulating evidence suggests that diet and lifestyle can play an important role in delaying
the onset or halting the progression of age-related health disorders and to improve cognitive function. A
growing number of dietary intervention studies in humans and animals and in particular those using
polyphenol-rich diets have been proposed to exert a multiplicity of neuroprotective actions within the brain,
including a potential to protect neurons against injury induced by neurotoxins, an ability to suppress
neuroinﬂammation and a potential to promote memory, learning, and cognitive functions. These effects
appear to be underpinned by two common processes. First, they are capable of interactions with critical
protein and lipid kinase signalling cascades in the brain, leading to an inhibition of apoptosis triggered by
neurotoxic species and to a promotion of neuronal survival and synaptic plasticity. Second, they induce
beneﬁcial effects on the vascular system, leading to changes in cerebrovascular blood ﬂow capable of
causing enhance vascularisation and neurogenesis, two events important in the maintenance of cognitive
performances. Together, these processes act to maintain brain homeostasis and play important roles in
neuronal stress adaptation and thus polyphenols might have the potential to prevent the progression of
neurodegenerative pathologies.
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Over the last decade, a vast and growing research
literature has been focusing on the potential of dietary
polyphenols for aiding preservation of cognitive function
during ageing while reducing risk for neurodegenerative
disorders (Letenneur et al., 2007; Nurk et al., 2009; Gu et al.,
2010; Nooyens et al., 2011; Solfrizzi et al., 2011; Loef and
Walach, 2012; Vauzour, 2012). For example, the regular
dietary intake of polyphenol-rich foods and/or beverages has
been associated with 50% reduction in the risk of dementia
(Commenges et al., 2000), a preservation of cognitive
performance with ageing (Morris et al., 2006; Letenneur
et al., 2007), a delay in the onset of Alzheimer's disease (Dai
et al., 2006; Pasinetti et al., 2015) and a reduction in the risk
of developing Parkinson's disease (Checkoway et al., 2002;
Chen et al., 2015). It is now widely accepted that the
biological actions of polyphenols within the nervous system
are not solely due to their classical hydrogen donating
antioxidant activity (Williams et al., 2004). Rather, it has
become evident that polyphenols are more likely to exert
beneﬁcial effects in the brain (at low and physiological
concentrations) by preventing neurodegeneration, inhibiting
neuroinﬂammation and reducing age-related cognitive de-
cline (Vauzour et al., 2008; Vauzour, 2012). In particular,ding author: D.Vauzour@uea.ac.uk
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pathways, critical in controlling synaptic plasticity and a
potential to induce vascular effects capable of causing
new nerve cell growth in the hippocampus (Spencer et al.,
2009; Vauzour, 2012). This review will describe the potential
of polyphenols to modulate brain functions and will
summarise the possible mechanisms implicated in such
beneﬁcial effects.
2 Polyphenols structure and occurrence
Polyphenols are a group of naturally occurring phyto-
chemicals which are present in high amounts in fruits and
vegetables. These compounds are characterised by the
presence of multiple hydroxyl groups on aromatic rings and
are divided into two main categories, the ﬂavonoids and non-
ﬂavonoids, based on the number of phenol rings and the way in
which these rings interact.
Flavonoids have aC6–C3–C6 structure and share a common
feature which consist of two aromatic carbon rings, benzopyran
(A and C rings) and benzene (B ring), and may be divided in
various subgroups based on the degree of the oxidation of the
C-ring, the hydroxylation pattern of the ring structure and the
substitution of the 3-position. The main dietary groups of
ﬂavonoids are: (1) ﬂavones (e.g. apigenin, luteolin), which are
found in parsley and celery; (2) ﬂavonols (e.g. kaempferol,
quercetin), which are found in onions, leeks, broccoli;ttribution License (http://creativecommons.org/licenses/by/4.0), which permits
edium, provided the original work is properly cited.
D. Vauzour: OCL(3) isoﬂavones (e.g.daidzein, genistein),whicharemainly found
in soy and soy products; (4) ﬂavanones/ﬂavanonols (e.g.
hesperetin, naringenin/astilbin, engeletin), which are mainly
found in citrus fruit, herbs (oregano) andwine; (5)ﬂavanols (e.g.
(þ)-catechin, ()-epicatechin, epigallocatechin, epigallocate-
chin gallate (EGCG)),which are abundant in green tea, redwine,
chocolate; and (6) anthocyanidins (e.g. pelargonidin, cyanidin,
malvidin), whose sources include red wine and berry fruits.
The non-ﬂavonoid group may be separated into two
different classes: (1) the phenolic acids, including the
hydroxybenzoic acids (C1–C3 skeleton; i.e. protocatechuic
and gallic acids) and hydroxycinnamic acids (C3–C6 skeleton;
i.e. caffeic and chlorogenic acids) together found in many
fruits and vegetables; (2) the stilbenes (C6–C2–C6 structure;
i.e. resveratrol) found in grapes, wine, peanuts. For further
details of the structures and occurrence of these compounds
readers should consult Rodriguez-Mateos (Rodriguez-Mateos
et al., 2014), along with the ever expanding Phenol-Explorer
database which includes comprehensive information of the
polyphenol content of foods (Neveu et al., 2010).
3 Effects of polyphenols on age-related
cognitive decline and neurodegenerative
disorders
Ageing is a normal and inevitable process in life. It
progressesmore or less rapidly depending on our lifestyle habits
(sedentary, western-type diet, alcohol, and smoking). The
normal brain ageing affects the frontal and temporal lobes more
than the parietal and occipital lobes (Bentourkia et al., 2000) and
is characterised by a progressive decline in cognitive abilities
mainly in hippocampal circuit, including the dentate gyrus, and
the prefrontal cortex (for long-term memory) (Morrison and
Baxter, 2012). In addition, past and recent research shows that
the ageing process causes declines in both motor and cognitive
functions even in absence of neurodegenerative disease, in both
animals (Ingram et al., 1994; Shukitt-Hale et al., 1998) and
humans (West, 1996; Muir, 1997). Alterations in cognition
appear to occur primarily in secondarymemory systems, such as
memory performance (e.g. delayed recall of a story presented
once) (Dixon et al., 2004), processing, working memory
(Corona et al., 2013), and executive function (Siedlecki et al.,
2005). Increased fruits and vegetables intake has been
associated with improved cognitive function (Soﬁ et al.,
2010; Tangney et al., 2011; Lamport et al., 2016), andmay be in
large part attributable to intake of polyphenols (Barberger-
Gateau et al., 2007). In particular, increased consumption of
polyphenols was positively associated with better language and
episodic memory in middle-aged healthy adults (45–60 years
old) (Kesse-Guyot et al., 2012) and with a greater cognitive
performance at baseline and less decline across the follow-up
assessments in non-demented adults aged 70 and over
(Letenneuret al., 2007). Similarly, greater intakes of blueberries
and strawberries anthocyaninswere associatedwith slower rates
of cognitive decline in non-demented adults aged 70 and over
(Devore et al., 2012). Blueberry appears to have a pronounced
effect on short-term (Ramirez et al., 2005) and long-term
memory (Casadesus et al., 2004), and animal studies have
provided further evidence for the efﬁcacy of blueberries
(Williams et al., 2008; Rendeiro et al., 2012), indicating thatPage 2improvements in spatial memory may emerge within 3 weeks,
the equivalent of about 3 years in humans. In addition, pure
()-epicatechin (500mg/g) was observed to enhance the
retention of spatial memory in C57BL/6 mice (8–10 week
old), especially when combined with exercise (van Praag et al.,
2007), similarly to green tea catechins (0.025–0.1%w/v)
(Li et al., 2009a). The mechanisms seem to involve an indirect
action on the dentate gyrus (DG) (Casadesus et al., 2004; Burke
and Barnes, 2006; Rendeiro et al., 2012; Rendeiro et al., 2013).
Such link between hippocampal neurogenesis, cognitive
performance and ageing may represent a potential mechanism
by which polyphenol-derived foods may improve memory
(Stangl and Thuret, 2009). However, although epidemiological
and pre-clinical studies have lent some support to the
neurocognitive potential of polyphenols, human intervention
results are less clear (Scholey et al., 2010; Field et al., 2011) and
further work is still necessary to conﬁrm these preliminary
observations (Vauzour et al., 2016).
Inaddition toage-relatedcognitivedecline, epidemiological,
preclinical and clinical studies have also explored the neuro-
protective effect of natural compounds in clinical conditions
(Commengesetal., 2000;Letenneuretal., 2007;Pasinetti, 2015;
Pasinetti et al., 2015). Verbal learning was improved in older
adults withmild cognitive impairment (MCI) after consumption
of Concord grape juice (Krikorian et al., 2010a), blueberry juice
(Krikorian et al., 2010b) and ﬂavanols (Desideri et al., 2012).
Although the exactmechanisms underlying these improvements
are not clear, it has been suggested that polyphenols may delay
the initiation of and/or slow the progression of Alzheimer's
Disease (AD)-like pathology, including a potential to inhibit
neuronal apoptosis triggered by neurotoxic species (e.g.
oxidative stress and neuroinﬂammation) (Vauzour et al.,
2007a; Mori et al., 2012; Cox et al., 2015). Polyphenols can
reduce amyloid-beta (Ab) plaque pathology (Hirohata et al.,
2007;Amit et al., 2008;Ehrnhoeferet al., 2008;Ono et al., 2008;
Wang et al., 2014), and therefore they could have utility in AD
beyond anti-Ab processing (Wang et al., 2015). For example,
oral administration of epigallocatechin-3-gallate (EGCG,
50mg/kg) for 6months inmicewhich over-express the Swedish
mutation ofAPP (APPsw; 8months old), reducedAb pathology
and improved cognition (Rezai-Zadeh et al., 2008). Long term
green tea catechin administration (0.05–0.1%w/v) also im-
proved spatial learning and memory in senescence prone mice,
by decreasing Ab1–42 oligomers and upregulating synaptic
plasticity-related proteins in the hippocampus (Li et al., 2009b).
However, a recent investigation reported a cognitive-enhancing
effect of a polyphenol-rich without changes in either Ab or Tau
pathologies, therefore suggesting that polyphenols-rich extracts
may prevent memory impairment associated with age-related
diseases, without signiﬁcant effects on classical AD neuropa-
thology (Dal-Panet al., 2017). Furtherwork is therefore required
to fully apraisewhether polyphenols have efﬁcacy in individuals
affected by dementia.
4 Cellular and molecular interactions
underlying the cognitive effects of
polyphenols
It has generally been assumed that the health beneﬁts of
polyphenols were linked to their capacity to directly scavengeof 7
D. Vauzour: OCLfree radicals and other nitrogen species in vitro (Pannala et al.,
1997; Visioli et al., 1998; Russo et al., 2000; Halliwell, 2006).
However, the concentrations at which they exert such
antioxidant activity is unlikely to be easily achieved in vivo
as many polyphenols have very limited bioavailability and are
extensively metabolised in the gut and the liver (Rodriguez-
Mateos et al., 2014). Instead, recent ﬁndings have suggested
that in lower amounts, typical of those attained in the diet,
polyphenols may exert pharmacological activity within the
cells with mechanisms that go beyond the classic antioxidant
scavenging mechanisms (Williams et al., 2004; Vauzour et al.,
2010). In particular, polyphenols are capable of modulating
intracellular signalling cascades (Spencer et al., 2009; Vauzour
et al., 2010; Kuo et al., 2015), gene expression and interactions
with mitochondria (Schroeter et al., 2001; Schroeter et al.,
2007; Vauzour et al., 2007b; Mandel et al., 2008). By affecting
such pathways, they have the potential to induce new protein
synthesis in neurons and thus an ability to induce morphologi-
cal changes, which have a direct inﬂuence on memory
acquisition, consolidation and storage. Alternatively, their well
established effects on the vascular system may also induce
increases in cerebral blood ﬂow capable of impacting on acute
cognitive performance, or may lead to an increase hippocam-
pal vascularisation capable of inducing new neuronal growth.
4.1 Polyphenols affect signalling cascades involved
in synaptic plasticity maintenance
The activation of various signalling pathways have been
linked with the control of synaptic plasticity and memory
(Spencer et al., 2009) which all converge to the cAMP-response
element-binding protein (CREB), a transcription factor which
binds to the promoter regions of many genes associated with
synapse re-modelling, increases in neuronal spine density and
synaptic plasticity (Impey et al., 2004; Barco et al., 2006). Such
interactions may lead to improvements in memory through
induction of synapse growth and connectivity, increases in
dendritic spine density and the functional integration of old
and new neurons. As such, nutrients which interact with these
pathwaysmayalsobecapableof reducing theneurodegenerative
injury associated with major brain diseases.
There is much evidence to support the actions of
polyphenols on the ERK pathway (Schroeter et al., 2007;
Vauzour et al., 2007b), which often leads to the activation of
CREB (Corona et al., 2013), a transcription factor considered
to be critical in the induction of long-lasting changes in
synaptic plasticity and memory (Bourtchuladze et al., 1994;
Impey et al., 1998). Indeed, CREB activation regulates the
expression of a number of important genes, including the brain
derived neurotrophic factor (BDNF), thus playing a pivotal
role in controlling neuronal survival, and synaptic function in
the adult central nervous system (Finkbeiner, 2000; Tully
et al., 2003). Regulation of BDNF is of particular interest as
it is linked with the control of synaptic plasticity and long-
term memory (Finkbeiner et al., 1997; Carito et al., 2014).
Additionally, interactions are suggested to exist between
BDNF, age-related cognitive decline and other cognitive-
behavioural disorders. For example, age-related hippocampal
atrophy is associated with memory-impairment, and therefore
it is hypothesised that lower BDNF levels partly mediate thisPage 3physiological change (Erickson et al., 2012). Recent studies
have shown that spatial memory performance in rats
supplemented with blueberry, correlates well with the
activation of CREB and with increases of BDNF in the
hippocampus (Ramirez et al., 2005; Wang et al., 2011). In
agreement with these observation, two recently conducted
clinical trials reported concurrent changes in serum BDNF
levels and global cognition scores following high polyphenol
consumption, therefore suggesting a role for BDNF in
polyphenol-induced cognitive improvements (Neshatdoust
et al., 2016). As well as effects on the ERK/CREB/BDNF
axis, polyphenols are also known to modulate the activity of
Akt (also known as PKB), triggering the increased translation
of speciﬁc mRNA subpopulations (Vlahos et al., 1994),
including the activity-regulated cytoskeletal-associated pro-
tein (Arc/Arg3.1) (Ramirez et al., 2005), facilitating changes
in synaptic strength, and the induction of morphological
changes in dendritic spine density and outgrowth (Waltereit
et al., 2001).4.2 Polyphenols mitigate neuroinﬂammation
Growing evidence is also suggestive that cognitive decline
is in part mediated by an increase in neuroinﬂammatory stimuli
linked to over-production of microglia-derived pro-inﬂamma-
tory cytokines and reactive oxygen species. For example,
increased neuroinﬂammation and oxidative stress can perturb
the proper function of brain neurons, they can impede the
efﬁciency of long term potentiation required for new memory
formation, they can amplify the production and potentiate
the effects of the Ab protein. Since evidence emerged that
non-steroidal anti-inﬂammatory drugs may be effective in
delaying the onset of neurodegenerative disorders (Moore
and O'Banion, 2002), there has been much interest in the
development of new drugs capable of preventing neuro-
inﬂammatory mediated brain injury. Over the last years, efforts
have been made at investigating the effect polyphenols on
neuroinﬂammation. Although not exhaustive, the main anti-
inﬂammatory properties of polyphenols may be summarised
by (1) a capacity to downregulate the activity of pro-
inﬂammatory transcription factors such as NF-kB, Nrf2 or
STAT through their inﬂuences on a number of glial and
neuronal signalling pathways, (2) an inhibitory role on the
release of cytokines, such as interleukin IL-1b and TNF-a,
from primed microglia, (3) an inhibitory action against the
production of NO and PGE2 in response to microglia
activation, (4) an ability to inhibit the activation of NADPH
oxidase and subsequent ROS generation in activated glia,
and (5) an inhibitory action against microglia priming through
toll-like receptors (TLR) activation (Gonzalez-Gallego et al.,
2010; Vauzour, 2014). For example, ﬁsetin (0.05%, 6 months)
reduced the protein expression of inﬂammatory markers in
huAPPswe/PS1DE9 transgenic mice in an ERK-p25-mediated
pathway without affecting the mRNA expression of NF-kB1
(Currais et al., 2014). Similarly, kaempferol-3-O-rutinoside
(10mg/kg) and kaempferol-3-O-glucoside (7.5mg/kg) re-
duced the neuroinﬂammatory response by inhibiting signal
transducer and activator of transcription 3 (STAT3) and
NF-kB following an ischemic brain injury in rats (Yu et al.,
2013). In addition, intervention trial with an anthocyaninof 7
D. Vauzour: OCLextract from blueberries (300mg/d for 3 weeks) signiﬁcantly
reduced the plasma concentration of NF-kB-related pro-
inﬂammatory cytokines and chemokines (IL-4, IL-13, IL-8
and IFN-a) in a group of 120 men and women aged 40–74
years (Karlsen et al., 2007). However, no signiﬁcant effect has
been observed in plasma levels of CRP or ICAM-1 among
healthy volunteers consuming diets rich or poor in berries and
apple for 6 weeks (Freese et al., 2004). Equally, a 4-week
administration of quercetin signiﬁcantly increased plasma
levels of quercetin, but did not alter ex vivo LPS-induced TNF-
a levels (Boots et al., 2008). Although work carried out in cells
or animal models have lent some support to the anti-
inﬂammatory effect of polyphenols, the inconsistent outcome
of various clinical trials on the preventive anti-inﬂammatory
effect of polyphenols reinforces the necessity for more
prospective randomised trials with larger sample sizes, longer
follow-up in both healthy volunteers and in clinical conditions.4.3 Polyphenols-induced change in (cerebro)vascular
functions
Compelling evidence derived from human clinical studies
is suggesting that polyphenols can positively affect peripheral
(Hooper et al., 2008; Kay et al., 2012) and cerebrovascular
blood ﬂow (Schroeter et al., 2006; Heiss et al., 2007; Sorond
et al., 2008; Jagla and Pechanova, 2015), which may be an
indirect effective mechanism by these molecules could impact
on brain health and cognition. For example, a high-ﬂavanone
citrus juice (70.5mg/500ml) was associated with signiﬁcantly
increased regional perfusion in the inferior and middle right
frontal gyrus at 2 h relative to baseline and the control drink in
young healthy volunteers (Lamport et al., 2016). Similarly,
signiﬁcant increases in regional perfusion across the brain
were observed following consumption of a high ﬂavanol drink
relative to the low ﬂavanol drink, particularly in the anterior
cingulate cortex and the central opercular cortex of the parietal
lobe (Lamport et al., 2015). Longer-term interventions
(3 months) also with cocoa ﬂavanols in aged subjects revealed
increases in cerebral blood volume (fMRI) in the DG of the
hippocampus, which was highly correlated with improvements
in performance in the DG-dependent Modiﬁed Benton task
(Brickman et al., 2014). Furthermore, ageing is known to
impair vascularisation, endothelial function and decreases
endothelial progenitor cell recruitment, which could adversely
affect neurogenesis. Therefore, the inﬂuence of dietary agents
on angiogenesis (van Praag et al., 2007) and the production of
vascular derived factors are also likely to inﬂuence neuro-
genesis (Casadesus et al., 2004). Ultimately, the effects of
polyphenols on the hippocampus are likely to be very
dependent on local concentration and, at present, it remains
unclear whether polyphenols induce global changes in
hippocampal (and other brain region) morphology/function,
or are capable of inducing changes within speciﬁc hippocam-
pal sub-regions. However, if such effects prove possible, then
diet would have the potential to not only slow the progression
of neurodegeneration and cognitive decline, but also to
potentially reverse disease and cognitive impairment via the
re-population of neurons in the hippocampus. In summary,
despite clear evidence regarding the acute vascular effects of
ﬂavonoids shown in humans (Macready et al., 2010) andPage 4medium-term changes in synaptic plasticity markers demon-
strated in animal studies (Spencer, 2009), the basic mecha-
nisms of action of polyphenols in humans remains unclear,
due to a lack of precise causative/mechanistic data. Future
work should strive to determine the mechanistic basis of
polyphenol-induced improvements in cognitive function by
investigating the degree to which peripheral- and cerebral
blood ﬂow induced by polyphenol metabolites plays in
determining improvements in human cognitive performance,
in particular attention and episodic memory.
5 Conclusion
Decline on cognitive abilities with age occurs in healthy
individuals and spreads through adult lifespan. The mecha-
nisms contributing to normal aging, including oxidative stress,
neuroinﬂammation and vascular dysfunction are the same than
those contributing to the development of neurological diseases.
However, in pathological conditions these mechanisms are
exacerbated and are triggered by different factors which might
be genetic or environmental. The consumption of polyphenol-
rich foods throughout life holds a potential to limit neuro-
degeneration and prevent or reverse age-dependent deterio-
rations in cognitive performance. However, the therapeutic and
pharmacological potential of these natural compounds still
remains to be fully translated in humans and in clinical
conditions. The challenge ahead therefore, is to proceed
cautiously until rigorous randomized controlled clinical trials
have been undertaken to determine empirically whether
polyphenols and/or their in vivo metabolites have efﬁcacy
in individuals affected by dementia and other neurodegenera-
tive conditions.AbbreviationsADof 7Alzheimer's disease
APP amyloid precursor protein
Arc/Arg3.1 activity-regulated cytoskeleton-associated protein
(also known as Arg3.1)
Ab amyloid beta
BDNF brain derived neurotrophic factor
CREB c-AMP-response element binding protein
CRP C reactive protein
DG dentate gyrus
EGCG epigallocatechin-3-gallate
ERK extracellular signal-regulated kinases
fMRI functional magnetic resonance imaging
ICAM-1 Intercellular Adhesion Molecule 1





Nrf2 nuclear factor erythroid-related factor 2
PGE2 prostaglandin E2
ROS reactive oxygen species
STAT3 signal transducer and activator of transcription 3
TLR toll-like receptor
TNFa tumour necrosis factor alpha
D. Vauzour: OCLReferences
Amit T, Avramovich-Tirosh Y, Youdim MB, Mandel S. 2008.
Targeting multiple Alzheimer's disease etiologies with multi-
modal neuroprotective and neurorestorative iron chelators.
FASEB J 22: 1296–1305.
Barberger-Gateau P, Raffaitin C, Letenneur L, et al. 2007. Dietary
patterns and risk of dementia: the Three-City cohort study.
Neurology 69: 1921–1930.
Barco A, Bailey CH, Kandel ER. 2006. Common molecular
mechanisms in explicit and implicit memory. J Neurochem 97:
1520–1533.
Bentourkia M, Bol A, Ivanoiu A, et al. 2000. Comparison of regional
cerebral blood ﬂow and glucose metabolism in the normal brain:
effect of aging. J Neurol Sci 181: 19–28.
Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen
GR. 2008. In vitro and ex vivo anti-inﬂammatory activity of
quercetin in healthy volunteers. Nutrition 24: 703–710.
Bourtchuladze R, Frenguelli B, Blendy J, Ciofﬁ D, Schutz G, Silva
AJ. 1994. Deﬁcient long-term memory in mice with a targeted
mutation of the cAMP-responsive element-binding protein. Cell
79: 59–68.
Brickman AM, Khan UA, Provenzano FA, et al. 2014. Enhancing
dentate gyrus function with dietary ﬂavanols improves cognition
in older adults. Nat Neurosci 17: 1798–1803.
Burke SN, Barnes CA. 2006. Neural plasticity in the ageing brain.
Nat Rev Neurosci 7: 30–40.
Carito V, Venditti A, Bianco A, et al. 2014. Effects of olive leaf
polyphenols on male mouse brain NGF, BDNF and their receptors
TrkA, TrkB and p75. Nat Prod Res 28: 1970–1984.
Casadesus G, Shukitt-Hale B, Stellwagen HM, et al. 2004.
Modulation of hippocampal plasticity and cognitive behavior
by short-term blueberry supplementation in aged rats. Nutr
Neurosci 7: 309–316.
Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth
Jr. WT, Swanson PD. 2002. Parkinson's disease risks associated
with cigarette smoking, alcohol consumption, and caffeine intake.
Am J Epidemiol 155: 732–738.
Chen M, Wang T, Yue F, et al. 2015. Tea polyphenols alleviate motor
impairments, dopaminergic neuronal injury, and cerebral alpha-
synuclein aggregation in MPTP-intoxicated parkinsonian mon-
keys. Neuroscience 286: 383–392.
Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-
Gateau P, Dartigues JF. 2000. Intake of ﬂavonoids and risk of
dementia. Eur J Epidemiol 16: 357–363.
Corona G, Vauzour D, Hercelin J, Williams CM, Spencer JP. 2013.
Phenolic acid intake, delivered via moderate champagne wine
consumption, improves spatial working memory via the
modulation of hippocampal and cortical protein expression/
activation. Antioxid Redox Signal 19: 1676–1689.
Cox CJ, Choudhry F, Peacey E, et al. 2015. Dietary ()-epicatechin as
a potent inhibitor of betagamma-secretase amyloid precursor
protein processing. Neurobiol Aging 36: 178–187.
Currais A, Prior M, Dargusch R, et al. 2014. Modulation of p25 and
inﬂammatory pathways by ﬁsetin maintains cognitive function in
Alzheimer's disease transgenic mice. Aging Cell 13: 379–390.
Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. 2006. Fruit and
vegetable juices and Alzheimer's disease: the Kame Project. Am J
Med 119: 751–759.
Dal-Pan A, Dudonne S, Bourassa P, et al. 2017. Cognitive-enhancing
effects of a polyphenols-rich extract from fruits without changes
in neuropathology in an animal model of Alzheimer's disease.
J Alzheimers Dis 55: 115–135.Page 5Desideri G, Kwik-Uribe C, Grassi D, et al. 2012. Beneﬁts in cognitive
function, blood pressure, and insulin resistance through cocoa
ﬂavanol consumption in elderly subjects with mild cognitive
impairment: the Cocoa, Cognition, and Aging (CoCoA) study.
Hypertension 60: 794–801.
Devore EE, Kang JH, Breteler MM, Grodstein F. 2012. Dietary
intakes of berries and ﬂavonoids in relation to cognitive decline.
Ann Neurol 72(1): 135–143.
Dixon RA,Wahlin A, Maitland SB, Hultsch DF, Hertzog C, Backman
L. 2004. Episodic memory change in late adulthood: generaliz-
ability across samples and performance indices. Mem Cognit 32:
768–778.
Ehrnhoefer DE, Bieschke J, Boeddrich A, et al. 2008. EGCG redirects
amyloidogenic polypeptides into unstructured, off-pathway
oligomers. Nat Struct Mol Biol 15: 558–566.
Erickson KI, Miller DL, Roecklein KA. 2012. The aging hippocam-
pus: interactions between exercise, depression, and BDNF.
Neuroscientist 18: 82–97.
Field DT, Williams CM, Butler LT. 2011. Consumption of cocoa
ﬂavanols results in an acute improvement in visual and cognitive
functions. Physiol Behav 103: 255–260.
Finkbeiner S. 2000. CREB couples neurotrophin signals to survival
messages. Neuron 25: 11–14.
Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM,
Greenberg ME. 1997. CREB: a major mediator of neuronal
neurotrophin responses. Neuron 19: 1031–1047.
Freese R, Vaarala O, Turpeinen AM,MutanenM. 2004. No difference
in platelet activation or inﬂammation markers after diets rich or
poor in vegetables, berries and apple in healthy subjects. Eur J
Nutr 43: 175–182.
Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S,
Tunon MJ. 2010. Fruit polyphenols, immunity and inﬂammation.
Br J Nutr 104 (Suppl 3): S15–S27.
Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. 2010.
Food combination and Alzheimer disease risk: a protective diet.
Arch Neurol 67: 699–706.
Halliwell B. 2006. Oxidative stress and neurodegeneration: where are
we now? J Neurochem 97: 1634–1658.
Heiss C, Finis D, Kleinbongard P, et al. 2007. Sustained increase
in ﬂow-mediated dilation after daily intake of high-ﬂavanol
cocoa drink over 1 week. J Cardiovasc Pharmacol 49:
74–80.
Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, et al. 2007. The anti-
amyloidogenic effect is exerted against Alzheimer's beta-amyloid
ﬁbrils in vitro by preferential and reversible binding of ﬂavonoids
to the amyloid ﬁbril structure. Biochemistry 46: 1888–1899.
Hooper L, Kroon PA, Rimm EB, et al. 2008. Flavonoids, ﬂavonoid-
rich foods, and cardiovascular risk: a meta-analysis of random-
ized controlled trials. Am J Clin Nutr 88: 38–50.
Impey S, Smith DM, Obrietan K, Donahue R, Wade C, Storm DR.
1998. Stimulation of cAMP response element (CRE)-
mediated transcription during contextual learning. Nat Neurosci
1: 595–601.
Impey S, McCorkle SR, Cha-Molstad H, et al. 2004. Deﬁning the
CREB regulon: a genome-wide analysis of transcription factor
regulatory regions. Cell 119: 1041–1054.
Ingram DK, Spangler EL, Iijima S, et al. 1994. New pharmacological
strategies for cognitive enhancement using a rat model of age-
related memory impairment. Ann N Y Acad Sci 717: 16–32.
Jagla F, Pechanova O. 2015. Age-related cognitive impairment as
a sign of geriatric neurocardiovascular interactions: may
polyphenols play a protective role? Oxid Med Cell Longev
2015: 721514.of 7
D. Vauzour: OCLKarlsen A, Retterstol L, Laake P, et al. 2007. Anthocyanins inhibit
nuclear factor-kappaB activation in monocytes and reduce plasma
concentrations of pro-inﬂammatory mediators in healthy adults.
J Nutr 137: 1951–1954.
Kay CD, Hooper L, Kroon PA, Rimm EB, Cassidy A. 2012. Relative
impact of ﬂavonoid composition, dose and structure on
vascular function: a systematic review of randomised controlled
trials of ﬂavonoid-rich food products. Mol Nutr Food Res 56:
1605–1616.
Kesse-Guyot E, Fezeu L, Andreeva VA, et al. 2012. Total and speciﬁc
polyphenol intakes in midlife are associated with cognitive
function measured 13 years later. J Nutr 142: 76–83.
Krikorian R, Nash TA, Shidler MD, Shukitt-Hale B, Joseph JA.
2010a. Concord grape juice supplementation improves memory
function in older adults with mild cognitive impairment. Br J Nutr
103: 730–734.
Krikorian R, Shidler MD, Nash TA, et al. 2010b. Blueberry
supplementation improves memory in older adults. J Agric Food
Chem 58: 3996–4000.
Kuo PH, Lin CI, Chen YH, Chiu WC, Lin SH. 2015. A high-
cholesterol diet enriched with polyphenols from Oriental plums
(Prunus salicina) improves cognitive function and lowers brain
cholesterol levels and neurodegenerative-related protein expres-
sion in mice. Br J Nutr 113: 1550–1557.
Lamport DJ, Pal D, Moutsiana C, et al. 2015. The effect of ﬂavanol-
rich cocoa on cerebral perfusion in healthy older adults during
conscious resting state: a placebo controlled, crossover, acute
trial. Psychopharmacology (Berl) 232: 3227–3234.
Lamport DJ, Pal D, Macready AL, et al. 2016. The effects of
ﬂavanone-rich citrus juice on cognitive function and cerebral
blood ﬂow: an acute, randomised, placebo-controlled cross-over
trial in healthy, young adults. Br J Nutr 116: 2160–2168.
Letenneur L, Proust-Lima C, Le GA, Dartigues JF, Barberger-Gateau
P. 2007. Flavonoid intake and cognitive decline over a 10-year
period. Am J Epidemiol 165: 1364–1371.
Li Q, Zhao HF, Zhang ZF, et al. 2009a. Long-term administration of
green tea catechins prevents age-related spatial learning and
memory decline in C57BL/6 J mice by regulating hippocampal
cyclic amp-response element binding protein signaling cascade.
Neuroscience 159: 1208–1215.
Li Q, Zhao HF, Zhang HF, et al. 2009b. Long-term green tea catechin
administration prevents spatial learning and memory impairment
in senescence-accelerated mouse prone-8 mice by decreasing
Abeta1-42 oligomers and upregulating synaptic plasticity-related
proteins in the hippocampus. Neuroscience 163: 741–749.
Loef M, Walach H. 2012. Fruit, vegetables and prevention of
cognitive decline or dementia: a systematic review of cohort
studies. J Nutr Health Aging 16: 626–630.
Macready AL, Butler LT, Kennedy OB, Ellis JA, Williams CM,
Spencer JP. 2010. Cognitive tests used in chronic adult human
randomised controlled trial micronutrient and phytochemical
intervention studies. Nutr Res Rev 23: 200–229.
MandelSA,AmitT,KalfonL,ReznichenkoL,WeinrebO,YoudimMB.
2008. Cell signaling pathways and iron chelation in the neuro-
restorative activity of green tea polyphenols: special reference to
epigallocatechin gallate (EGCG). J Alzheimers Dis 15: 211–222.
Moore AH, O'Banion MK. 2002. Neuroinﬂammation and anti-
inﬂammatory therapy for Alzheimer's disease. Adv Drug Deliv
Rev 54: 1627–1656.
Mori T, Rezai-Zadeh K, Koyama N, et al. 2012. Tannic acid is a
natural beta-secretase inhibitor that prevents cognitive im-
pairment and mitigates Alzheimer-like pathology in transgenic
mice. J Biol Chem 287(9): 6912–6927.Page 6Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. 2006.
Associations of vegetable and fruit consumption with age-related
cognitive change. Neurology 67: 1370–1376.
Morrison JH, Baxter MG. 2012. The ageing cortical synapse:
hallmarks and implications for cognitive decline. Nat Rev
Neurosci 13: 240–250.
Muir JL. 1997. Acetylcholine, aging, and Alzheimer's disease.
Pharmacol Biochem Behav 56: 687–696.
Neshatdoust S, Saunders C, Castle SM, et al. 2016. High-ﬂavonoid
intake induces cognitive improvements linked to changes in
serum brain-derived neurotrophic factor: two randomised,
controlled trials. Nutr Healthy Aging 4: 81–93.
Neveu V, Perez-Jimenez J, Vos F, et al. 2010. Phenol-Explorer: an
online comprehensive database on polyphenol contents in foods.
Database (Oxford) 2010: bap024.
Nooyens AC, Bueno-de-Mesquita HB, van Boxtel MP, et al. 2011.
Fruit and vegetable intake and cognitive decline in middle-aged
men and women: the Doetinchem Cohort Study. Br J Nutr 106:
752–761.
Nurk E, Refsum H, Drevon CA, et al. 2009. Intake of ﬂavonoid-rich
wine, tea, and chocolate by elderly men and women is associated
with better cognitive test performance. J Nutr 139: 120–127.
Ono K, CondronMM, Ho L, et al. 2008. Effects of grape seed-derived
polyphenols on amyloid beta-protein self-assembly and cytotox-
icity. J Biol Chem 283: 32176–32187.
Pannala AS, Rice-Evans CA, Halliwell B, Singh S. 1997. Inhibition of
peroxynitrite-mediated tyrosine nitration by catechin polyphe-
nols. Biochem Biophys Res Commun 232: 164–168.
Pasinetti GM. 2015. Novel role of red wine-derived polyphenols
in the prevention of Alzheimer's disease dementia and brain
pathology: experimental approaches and clinical implications.
Planta Med 78(15): 1614–1619.
Pasinetti GM,Wang J, Ho L, Zhao W, Dubner L. 2015. Roles of
resveratrol and other grape-derived polyphenols in Alzheimer's
disease prevention and treatment. Biochim Biophys Acta 1852:
1202–1208.
Ramirez MR, Izquierdo I, do Carmo Bassols Raseira M, Zuanazzi JA,
Barros D, Henriques AT. 2005. Effect of lyophilised Vaccinium
berries on memory, anxiety and locomotion in adult rats.
Pharmacol Res 52: 457–462.
Rendeiro C, Vauzour D, Kean RJ, et al. 2012. Blueberry supplementa-
tion induces spatial memory improvements and region-speciﬁc
regulation of hippocampal BDNFmRNA expression in young rats.
Psychopharmacology (Berl) 223: 319–330.
Rendeiro C, Vauzour D, Rattray M, et al. 2013. Dietary levels of pure
ﬂavonoids improve spatial memory performance and increase
hippocampal brain-derived neurotrophic factor. PLoS One 8:
e63535.
Rezai-Zadeh K, Arendash GW, Hou H, et al. 2008. Green tea
epigallocatechin-3-gallate (EGCG) reduces beta-amyloid medi-
ated cognitive impairment and modulates tau pathology in
Alzheimer transgenic mice. Brain Res 1214: 177–187.
Rodriguez-Mateos A, Vauzour D, Krueger CG, et al. 2014.
Bioavailability, bioactivity and impact on health of dietary
ﬂavonoids and related compounds: an update. Arch Toxicol 88:
1803–1853.
Russo A, Acquaviva R, Campisi A, et al. 2000. Bioﬂavonoids as
antiradicals, antioxidants and DNA cleavage protectors. Cell Biol
Toxicol 16: 91–98.
Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell
CF. 2010. Consumption of cocoa ﬂavanols results in acute
improvements in mood and cognitive performance during
sustained mental effort. J Psychopharmacol 24: 1505–1514.of 7
D. Vauzour: OCLSchroeter H, Spencer JP, Rice-Evans C,Williams RJ. 2001. Flavonoids
protect neurons from oxidized low-density-lipoprotein-induced
apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and
caspase-3. Biochem J 358: 547–557.
Schroeter H, Heiss C, Balzer J, et al. 2006. ()-Epicatechin mediates
beneﬁcial effects of ﬂavanol-rich cocoa on vascular function in
humans. Proc Natl Acad Sci USA 103: 1024–1029.
Schroeter H, Bahia P, Spencer JPE, et al. 2007. ()-Epicatechin
stimulates ERK-dependent cyclic AMP response element activity
and upregulates GLUR2 in cortical neurons. J Neurochem 101:
1596–1606.
Shukitt-Hale B, Mouzakis G, Joseph JA. 1998. Psychomotor and
spatial memory performance in aging male Fischer 344 rats.
Exp Gerontol 33: 615–624.
Siedlecki KL, Salthouse TA, Berish DE. 2005. Is there anything
special about the aging of source memory? Psychol Aging 20:
19–32.
Soﬁ F, Abbate R, Gensini GF, Casini A. 2010. Accruing evidence
on beneﬁts of adherence to the Mediterranean diet on health: an
updated systematic review and meta-analysis. Am J Clin Nutr 92:
1189–1196.
Solfrizzi V, Panza F, Frisardi V, et al. 2011. Diet and Alzheimer's
disease risk factors or prevention: the current evidence. Expert
Rev Neurother 11: 677–708.
Sorond FA, Lipsitz LA, Hollenberg NK, Fisher ND. 2008. Cerebral
blood ﬂow response to ﬂavanol-rich cocoa in healthy elderly
humans. Neuropsychiatr Dis Treat 4: 433–440.
Spencer JP. 2009. The impact of ﬂavonoids on memory: physiological
and molecular considerations. Chem Soc Rev 38: 1152–
1161.
Spencer JP, Vauzour D, Rendeiro C. 2009. Flavonoids and cognition:
the molecular mechanisms underlying their behavioural effects.
Arch Biochem Biophys 492: 1–9.
Stangl D, Thuret S. 2009. Impact of diet on adult hippocampal
neurogenesis. Genes Nutr 4: 271–282.
Tangney CC, Kwasny MJ, Li H, Wilson RS, Evans DA, Morris MC.
2011. Adherence to a Mediterranean-type dietary pattern and
cognitive decline in a community population. Am J Clin Nutr 93:
601–607.
Tully T, Bourtchouladze R, Scott R, Tallman J. 2003. Targeting the
CREB pathway for memory enhancers. Nat Rev Drug Discov 2:
267–277.
van Praag H, Lucero MJ, Yeo GW, et al. 2007. Plant-derived ﬂavanol
()epicatechin enhances angiogenesis and retention of spatial
memory in mice. J Neurosci 27: 5869–5878.
Vauzour D. 2012. Dietary polyphenols as modulators of brain
functions: biological actions and molecular mechanisms under-
pinning their beneﬁcial effects. Oxid Med Cell Longev 2012:
914273.
Vauzour D. 2014. Effect of ﬂavonoids on learning, memory and
neurocognitive performance: relevance and potential implications
for Alzheimer's disease pathophysiology. J Sci Food Agric 94:
1042–1056.Page 7Vauzour D, Vafeiadou K, Corona G, Pollard SE, Tzounis X, Spencer
JP. 2007a. Champagne wine polyphenols protect primary cortical
neurons against peroxynitrite-induced injury. J Agric Food Chem
55: 2854–2860.
Vauzour D, VafeiAdou K, Rice-Evans C, Williams RJ, Spencer JP.
2007b. Activation of pro-survival Akt and ERK1/2 signalling
pathways underlie the anti-apoptotic effects of ﬂavanones in
cortical neurons. J Neurochem 103: 1355–1367.
Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer
JP. 2008. The neuroprotective potential of ﬂavonoids: a
multiplicity of effects. Genes Nutr 3: 115–126.
Vauzour D, Rodriguez-Mateos A, Corona G, Oruna-Concha MJ,
Spencer JP. 2010. Polyphenols and human health: prevention of
disease and mechanisms of action. Nutrients 2: 1106–1131.
Vauzour D, Camprubi-Robles M, Miquel-Kergoat S, et al. 2016.
Nutrition for the ageing brain: towards evidence for an optimal
diet. Ageing Res Rev, DOI: 10.1016/j.arr.2016.09.010.
Visioli F, Bellomo G, Galli C. 1998. Free radical-scavenging
properties of olive oil polyphenols. Biochem Biophys Res
Commun 247: 60–64.
Vlahos CJ, Matter WF, Hui KY, Brown RF. 1994. A speciﬁc inhibitor
of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-
4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241–
5248.
Waltereit R, Dammermann B,Wulff P, et al. 2001. Arg3.1/ArcmRNA
induction by Ca2þ and cAMP requires protein kinase A and
mitogen-activated protein kinase/extracellular regulated kinase
activation. J Neurosci 21: 5484–5493.
Wang D, Ho L, Faith J, et al. 2015. Role of intestinal microbiota in the
generation of polyphenol-derived phenolic acid mediated
attenuation of Alzheimer's disease beta-amyloid oligomerization.
Mol Nutr Food Res 59: 1025–1040.
Wang J, Varghese M, Ono K, et al. 2014. Cocoa extracts reduce
oligomerization of amyloid-beta: implications for cognitive
improvement in Alzheimer's disease. J Alzheimers Dis 41:
643–650.
Wang W, Wang F, Yang YJ, et al. 2011. The ﬂavonoid baicalein
promotes NMDA receptor-dependent long-term potentiation and
enhances memory. Br J Pharmacol 162: 1364–1379.
West RL. 1996. An application of prefrontal cortex function theory to
cognitive aging. Psychol Bull 120: 272–292.
Williams CM, El Mohsen MA, Vauzour D, et al. 2008. Blueberry-
induced changes in spatial working memory correlate with
changes in hippocampal CREB phosphorylation and brain-
derived neurotrophic factor (BDNF) levels. Free Radic Biol Med
45: 295–305.
Williams RJ, Spencer JP, Rice-Evans C. 2004. Flavonoids:
antioxidants or signalling molecules? Free Radic Biol Med 36:
838–849.
Yu L, Chen C, Wang LF, et al. 2013. Neuroprotective effect of
kaempferol glycosides against brain injury and neuroinﬂamma-
tion by inhibiting the activation of NF-kappaB and STAT3 in
transient focal stroke. PLoS One 8: e55839.Cite this article as: Vauzour D. 2017. Polyphenols and brain health. OCL, DOI: 10.1051/ocl/2017008of 7
